Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002110

Chief Discovery/Trans Medicine sold 10,338 shares at an average $38.38 ($396,738)

  • Chief Discovery/Trans Medicine acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hamilton James C · Chief Discovery/Trans Medicine

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Sale : show line 1 in the form −1,194 $37.46 $44,727 154,431 D
2023-01-03 Sale : show line 2 in the form −2,837 $38.53 $109,310 151,594 D
2023-01-03 Sale : show line 3 in the form −300 $39.74 $11,922 151,294 D
2023-01-03 Sale : show line 4 in the form −136 $40.54 $5,513 151,158 D
2023-01-03 Sale : show line 5 in the form −1,642 $37.49 $61,559 149,516 D
2023-01-03 Sale : show line 6 in the form −3,682 $38.52 $141,831 145,834 D
2023-01-03 Sale : show line 7 in the form −300 $39.56 $11,868 145,534 D
2023-01-03 Sale : show line 8 in the form −247 $40.52 $10,008 145,287 D
2023-01-04 Grant or award : show line 9 in the form +60,000 205,287 D
Open-market sales · 10,338 sh · avg $38.38 · $396,738
Loading xslF345X03/doc4.xml…